Cowen Upgrades ARIAD Pharmaceuticals (ARIA) to Outperform
Tweet
Share
E-mailGet Alerts ARIA Hot Sheet
Price: $24.82 -0.48%
Rating Summary:
10 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Rating Summary:
10 Buy, 12 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 12 | Down: 15 | New: 40
Join SI Premium – FREE
Cowen upgraded ARIAD Pharmaceuticals (NASDAQ: ARIA) from Market Perform to Outperform with a price target of $10.00.
For an analyst ratings summary and ratings history on ARIAD Pharmaceuticals click here. For more ratings news on ARIAD Pharmaceuticals click here.
Shares of ARIAD Pharmaceuticals closed at $6.73 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Sunway Healthcare Holdings (SUNMED:MK) to Buy
- KeyBanc Upgrades Innovage Holding Corp (INNV) to Overweight
- Freedom Broker Upgrades Walmart (WMT) to Buy
Create E-mail Alert Related Categories
UpgradesRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
